|Support type:||Scholarships in Brazil - Scientific Initiation|
|Effective date (Start):||August 01, 2020|
|Effective date (End):||July 31, 2021|
|Field of knowledge:||Health Sciences - Medicine - Medical Clinics|
|Principal Investigator:||Ligia Yukie Sassaki|
|Grantee:||Clara Miracco Urbinati|
|Home Institution:||Faculdade de Medicina (FMB). Universidade Estadual Paulista (UNESP). Campus de Botucatu. Botucatu , SP, Brazil|
Inflammatory Bowel Diseases (IBD) - Crohn's Disease (CD) and Ulcerative Colitis (UC)- are chronic and idiopathic conditions whose symptoms include diarrhea, abdominal pain, weight loss and incontinence. They may compromise the quality of life of their carriers and may have a negative impact on body image. Body image is each person's concept of their own physical appearance and their perception of how others see them. Body image has a major influence on social interactions and relationships, and individuals with a negative body image may experience feelings of shame and anxiety about their physical appearance, as well as depressive symptoms, sexual problems and low self-esteem. Objectives: To evaluate the impact of the disease on the body image of patients with IBD and cand assess the clinical and psychological factors associated with impaired body image in patients with IBD. Identify factors associated with body image impairment such as disease activity, gender and age. Methodology: A cross-sectional study will be conducted with outpatient interviews and the data will be compared with the control group. Patients with IBD will be selected from a sample of 100 patients. Healthy people of the same age and gender will be selected for the control group. Data such as age, sex, disease duration and lifestyle habits such as smoking will be analyzed. CD will be assessed by the Montreal Classification and its activity by the Crohn's Disease Activity Index (CDAI); UC will be assessed for extent and activity by the Mayo Score. Body image will be assessed by the Body Image Scale (BIS). Quality of life will be assessed using the SF-36 questionnaire. The presence of anxious and depressive symptoms will be assessed by the Anxiety and Depression Scale (HADS). Self-esteem will be assessed using the Rosemberg Self-Esteem Scale. Statistical Analysis: descriptive and association tests.